PROFUSA INC (PFSA:NASDAQ)
$0.7037 -0.1613 (-18.6474%)
Analysed PROFUSA INC (PFSA:NASDAQ) News Sources
Profusa Expands into Multi-Billion Dollar Precision Diagnostics Market with $30M Letter of Intent for a PanOmics Platform
06-04-2026
yahoo.com
Profusa To Withdraw S-1 Registration Statement to Pursue a Smaller, More Focused Offering
27-02-2026
yahoo.com
Profusa Receives Purchase Orders for Lumee™ Tissue Oxygen Monitoring and Raises 2026 Revenue Guidance
19-02-2026
yahoo.com
Profusa and Mayo Clinic collaborate to Advance High-Impact Clinical Applications of Oxygen Monitoring Technologies
13-02-2026
yahoo.com
Profusa Announces 1-for-75 Reverse Stock Split
05-02-2026
yahoo.com
Profusa Presents Positive US-Study Clinical Results at Leipzig Interventional Course (LINC) 2026
29-01-2026
yahoo.com
Profusa Launches Lumee™ Tissue Oxygen Healthcare Research Offerings, Initiating First Commercial Revenue
16-01-2026
yahoo.com
Profusa Adds Leading Greek Vascular Surgeon to Customer Base
08-01-2026
yahoo.com
Profusa Bolsters European Commercial Network with New French Distributor, MedSell
31-12-2025
yahoo.com
Profusa Restructures Senior Secured Convertible Notes, Only Convertible Above $0.35
30-12-2025
yahoo.com
What is the current price of PROFUSA INC (PFSA:NASDAQ)?
The current price of PROFUSA INC (PFSA:NASDAQ) is $0.7037.
PROFUSA INC (PFSA:NASDAQ) absolute price change since previous trading day?
The absolute price change of PROFUSA INC (PFSA:NASDAQ) since the previous trading day is $-0.1613.
PROFUSA INC (PFSA:NASDAQ) percentage price change since previous trading day?
The percentage price change of PROFUSA INC (PFSA:NASDAQ) since the previous trading day is -18.6474%.
What is the most recent average sentiment score for PROFUSA INC (PFSA:NASDAQ)?
The most recent average sentiment score for PROFUSA INC (PFSA:NASDAQ) is 86 out of 100.
What is the most recent average sentiment for PROFUSA INC (PFSA:NASDAQ)?
The most recent sentiment for PROFUSA INC (PFSA:NASDAQ) is .
SEC-8K** Filing Available For PROFUSA INC (PFSA:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.